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Great burdock (Arctium lappa) is an edible vegetable that is also used as herbal medicines in many countries. 
Traditionally, burdock is used to slow aging, cure male impotence and in beauty care. However, the relevant mecha-
nisms and scientific proof of its actions have not yet been elucidated. The expansion of the corpora cavernosum 
smooth muscle cells of the penis is the main regulating factor of erection, and the nitric oxide−soluble guanylyl 
cyclase−cyclic guanine monophosphate (NO-sGC-cGMP) pathway plays an important role in maintaining expansion of 
the corpora cavernosum. The current study aims are to investigate the effects of burdock extract on a rabbit’s cor-
pora cavernosum. The effects of burdock on the protein expression in the cavernosum tissues and smooth muscle 
cells were investigated, and the changes in cGMP level were determined via enzyme-linked immunosorbent assay kit 
analysis. Our results showed that burdock extract increased the expression of neuronal nitric oxide synthase, cGMP-
dependent kinase, sGCα1 and sGCβ1 in the smooth muscle cells and tissues of the corpora cavernosum, while the 
expression of phosphodiesterase-5 was inhibited. Additionally, cGMP levels become elevated in the smooth muscles 
after treatment with burdock extract. In summary, our data suggest that burdock can facilitate in the relaxation of 
the corpora cavernosum; however, the benefits of burdock in treating erectile dysfunction remain to be resolved.
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Introduction
Arctium lappa, Linn is a herbaceous plant classified 
in the Asteraceae family, and its common English 
name is great burdock. Burdock roots are similar in 
shape to those of Ginseng. The abundant nutrients 
of Arctium lappa Linn include inulin,1 polyphenols, 
chlorogenic acid, proteins, carbohydrates, vitamins, 
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amino acids, minerals, and unsaturated fatty acids. 
Inulin is a polysaccharide that stimulates hormonal 
secretion, improves strength, muscular and skeletal 
development and reduces male impotence. Aside 
from being a food, Arctium lappa Linn may also be 
used as medicine. The aglycone in burdock is an ac-
tive ingredient that inhibits urinary protein excretion, 
and can improve serum biochemical indicators.2,3 
It is demonstrated to have anti-nephritis activity, 
and can be used to treat acute nephritis, nephrotic 
syndrome, and prevent senile dementia.4,5 Moreover, 
the ingredients of burdock have been shown to re-
duce acid-induced chronic gastric ulcers, reduce ox-
idative stress and cell injury in liver cells,2,3 and exhibit 
anti-tumor activity.6 Pharmaceutical companies have 
also developed Arctium lappa Linn as a health 
supplement for the market.
Erectile dysfunction (ED), known as male impo-
tence, is a sexual dysfunction in which men are un-
able to achieve full erections or can sustain only brief 
erections for sexual performance.7,8 While erectile 
dysfunction can occur at any age, it is more common 
in the elderly. The penis contains two chambers, 
called the corpora cavernosum, which run the length 
of the upper side of the penis. Filling the corpora 
cavernosum is a spongy tissue consisting of smooth 
muscles, fibrous tissues, spaces, veins, and arteries. 
An erection occurs as a hydraulic effect due to blood 
entering and being retained in sponge-like bodies 
within the penis. The pathogenesis of psychogenic 
ED is still unclear. However, it was suggested that 
organic and psychogenic factors may cause an abnor-
mal function in the NO-cGMP pathway and affect the 
smooth muscle relaxation, thereby resulting in ED.9
It is known that nitric oxide (NO) facilitates in 
the functions of the smooth muscles of the corpora 
cavernosum.10 Nitric oxide induces the functions 
of GTP and leads to the release of large amounts of 
cyclic guanine monophosphate (cGMP), which in turn 
activates the cGMP-dependent kinase (PKG) inside 
the muscle cells.11 The kinase then phosphorylates 
ion channels and decreases the calcium concentra-
tion inside the cells, leading to relaxation of the 
corpus cavernosum.12 As a result, the blood flow and 
perfusion in the cavernous artery increases, the 
corpus cavernosum and cavernous sinus expand, and 
the cavernous vein is obstructed. Erection is then 
achieved when the blood inflow is greater than 
outflow.10,13
The relaxation of smooth muscles of the cor-
pora cavernosum is the main regulating factor of 
erection, and NO-soluble guanylyl cyclase (sGC)-
cGMP regulating pathway plays an important role in 
maintaining the relaxation of the smooth muscles 
of the corpora cavernosum. The goals of the cur-
rent study are to investigate the effects of burdock 
extract on the copora cavernosum of rabbits by 
detecting the expression of the NO-sGC-cGMP path-
way related proteins and the changes of cGMP level 
in the smooth muscle cells of the corpora cavernosum 
treated with burdock extract.
Materials and Methods
Culture of smooth muscle cells of corora 
cavernosum
Male white rabbits were provided from National 
Laboratory Animal Breeding and Research Center 
(Taipei, Taiwan) and housed under conditions of 
constant temperature and controlled illumination. 
All animals used for this study were approved by the 
Animal Care and Use Committee at the Kaohsiung 
Medical University. The excised rabbit corpora cav-
ernosum tissues were cultured in Dulbecco’s modi-
fied Eagle’s medium (Invitrogen Corp., Carlsbad, 
CA, USA) containing 20% fetal bovine serum, 2 mM 
L-glutamine, penicillin (100 U/mL), streptomycin 
(0.1 mg/mL), and amphotericin B (0.25 μg/mL). 
After the cell concentration had reached 90% con-
fluency, cells were washed in phosphate buffered 
saline and treated with 0.05% trypsin/0.02% EDTA at 
37ºC. After cells detached from the plate, 4 mL 
medium containing serum was added to the culture 
to halt the actions of the trypsin. Cell suspensions 
were placed in sterile centrifuge tubes and washed 
with a medium once in a centrifuge. A fraction of cell 
pellets was used in subsequent cultures. The mor-
phology of the smooth muscle cells were confirmed 
under optical microscope.
Drug toxicity test
Burdock extracts were provided by the manufac-
turer (Dong Yuan Biotech Pharmaceutical Co., Ltd, 
Taiwan) and was extracted by water at 95ºC. 
The extracted solution was filtered and then 
freeze dried. MTT [3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide] assay was used 
to assess drug toxicity. Smooth muscle cells were 
cultured in 24-well plates at a concentration of 105 
cells per well. After culturing for 24 hours, cells 
were treated with indicated concentrations (0.2, 
0.4, 0.6, 0.8, 1 mg/mL) of burdock extract for 24 
hours. The medium was removed and 0.5 mg/mL of 
MTT reagent was added to the wells and incubated 
for 4 hours. The medium was again removed and 
300 μL of acidified isopropanol was added to dis-
solve the purple crystallized formazan on the bot-
tom of the wells. The supernatants (100 μL) were 
transferred to a 96-well plate and the absorbance 
at 540 nm (OD540) and 630 nm (OD630) was measured 
using a spectrophotometer. Cytoxicity of burdock 
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extract was expressed as the survival rate of the 
treated cells, which was designated as the ratio 
between the differences in absorbance (OD540 − 
OD630) of the treated group versus that of un-
treated control group.
Western blot
Corpora cavernosum smooth muscles cells were 
treated with burdock extract (0.2, 0.4, 0.6, 0.8, 
1 mg/mL) for 24 hours, while the excised rabbit 
cavernosum tissues were cut into sections, placed 
in Kreb’s solution and were treated with burdock 
extract (0.2, 0.4, 0.6, 0.8, 1 mg/mL) for 30 minutes. 
Then the treated cells or tissues were lysed for de-
tecting the protein expression of neuronal nitric 
oxide synthase (nNOS), phosphodiesterase-5 (PDE-5), 
PKG, sGCα1 and sGCβ1. The smooth muscle cells of 
the extract-treated cavernosum were washed twice 
with phosphate buffered saline, and then treated 
with lysis buffers for 15 minutes to detach the cells. 
Cells were then scraped off the plates with spatulas 
and centrifuged at 15,000g for 30 minutes under 
4ºC to obtain supernatants. The protein concentra-
tions in the supernatants were determined using 
Bio-Rad DC Protein Assay (Bio-Rad Laboratories, 
Inc., Hercules, CA, USA). Equal amounts of samples 
were loaded in the wells and sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed.
An equal amount of protein per sample was 
resolved on SDS-PAGE and transferred onto a PVDF 
membrane (PerkinElmer Inc., Waltham, MA, USA). 
The transferred membranes were blocked for 
1 hour in 5% nonfat milk in t-TBS and incubated with 
appropriate primary antibodies and horseradish 
peroxidase-conjugated secondary antibodies. The 
immune complexes were detected by Pierce ECL 
Chemiluminescent substrate kit (Thermo Fisher 
Scientific Inc., Waltham, USA).
Measurement of cyclic GMP
The smooth muscles of the drug-treated corpora 
cavernosum were placed in 0.1 N HCl for extracting 
cGMP, and cGMP concentration was determined using 
a commercially available enzyme-linked immuno-
sorbent assay kit (Amersham Pharmacia Biotech Inc., 
Piscataway, NJ, USA).
Statistical analyses
All data were analyzed by using SPSS version 12.0 
(SPSS Inc., Chicago, IL, USA). The experimental data 
was represented as mean ± standard error of the 
mean and the statistical differences were analyzed 
with Student’s t test. Additionally, repeated-measure 
analysis of variance was used to compare results 
between multiple sample groups and one control 
group. The Dunnett’s test was used to compare the 
mean differences between sample groups after 
analysis of variance was performed. Statistical signifi-
cance was denoted by a p value less than 0.05.
Result
Figure 1 depicts the cellular morphology of the cul-
tured smooth muscle cells of the corpora caverno-
sum, extracted from the cavernosum tissues of 
rabbits. To determine whether burdock extract con-
fers cytotoxicity to the smooth muscle cells, via-
bility of burdock extract-treated cells was measured. 
As shown in Figure 2, at concentrations ranging 
Figure 1 Morphology of corpora cavernosum smooth 
muscle cells (200×).
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Figure 2 MMT assay of burdocks on corpora cavernosum 
smooth muscle cells treated with burdock extract (0.2, 
0.4, 0.6, 0.8, 1 mg/mL) for 24 hr. Changes in survival rate 
represented percentages of untreated control group. Bars 
represent the mean ± standard error of the mean from 
at least three independent experiments.
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from 0.2 to 1 mg/mL, burdock extract does not in-
duce death of the smooth muscle cells. Therefore, 
the changes in the protein expressions of the cav-
ernosum smooth muscle cells should not be attrib-
uted to the cytotoxic effect of burdock extract.
As shown in Figure 3, when the cavernosum 
smooth muscle cells were treated with burdock ex-
tract for 24 hours, the expression of nNOS was in-
creased at burdock concentrations of 0.4, 0.6, 0.8 
and 1 mg/mL (Figure 3A), PDE-5 expression was 
significantly inhibited at concentrations of 0.6, 0.8 
and 1 mg/mL (Figure 3B), and PKG expression was 
elevated at concentrations of 0.2, 0.4, 0.6 and 
0.8 mg/mL (Figure 3C) in the cavernosum smooth 
muscle cells. Elevation of nitric oxide will also in-
duce activation of soluble guanylate cyclase, which 
can be used to treat erectile dysfunction. The data 
showed that burdock extract increased the expres-
sions of sGCα1 (Figure 3D) and sGCβ1 (Figure 3E) in 
the cavernosum smooth muscle cells.
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Figure 3 Effects of burdock extract on (A) nNOS,
(B) PDE-5, (C) PKG, (D) sGCα1 and (E) sGCβ1 protein expres-
sion in corpora cavernosum smooth muscles cells, which 
were treated with burdock extract (0.2, 0.4, 0.6, 0.8, 
1 mg/mL) for 24 hr. Changes in protein levels normalized 
by β-actin were quantified and represented as percent-
ages of the control group. Bars represent the mean ± 
standard error of the mean from at least three inde-
pendent experiments. *p < 0.05 vs. control. Analysis of 
variance followed by Dunnett’s test. nNOS: neuronal 
nitric oxide synthase; PDE-5: phosphodiesterase-5; PKG: 
cGMP-depentdent kinase; sGC: soluble guanylyl cyclase.
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To determine in vivo effects of burdock extract 
on smooth muscle cells of cavernosum, the excised 
rabbit cavernosum tissues were also treated with 
burdock extract for 30 minutes. The results showed 
that burdock extract treatment increased nNOS 
expression (Figure 4A), inhibited PDE-5 expression 
(Figure 4B), increased PKG expression (Figure 4C), 
and activated sGCα1 (Figure 4D) and sGCβ1 (Figure 4E) 
in the cavernosum smooth muscles. Moreover, the 
cGMP level in the cavernosum was increased after 
treatment with burdock extract (Figure 5).
Discussion
NO induces cGMP increase, which in turn activates 
PKG in cavernosum smooth muscle cells.11 PKG then 
decreases the calcium concentrations in the cells, 
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Figure 4 Effects of burdock extract on (A) nNOS, 
(B) PDE-5, (C) PKG, (D) sGCα1 and (E) sGCβ1 protein expres-
sion in corpora cavernosum smooth muscles, which were 
treated with burdock extract (0.2, 0.4, 0.6, 0.8, 1 mg/mL) 
for 30 min. Changes in protein levels normalized by β-actin 
were quantified and represented as percentages of the 
control group. Bars represent the mean ± standard error of 
the mean from at least three independent experiments. 
*p < 0.05 vs. control. Analysis of variance followed by 
Dunnett’s test. nNOS: neuronal nitric oxide synthase; PDE-
5: phosphodiesterase-5; PKG: cGMP-depentdent kinase; 
sGC: soluble guanylyl cyclase.
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which will result in relaxation of the cavernosum 
smooth muscles.12 The enzyme PDEs are known to 
hydrolyze cAMP and cGMP,14 and thus inhibits in-
crease in the concentration of cGMP in the caver-
nosum. Moreover, increase in the activity of PKG 
will decrease intracellular calcium concentration and 
induce relaxation of the smooth muscles, leading 
to erection.
NO plays an important role in the cavernosum 
smooth muscle cells. It is known that NO is synthe-
sized from L-arginine by the nNOS, which in turn 
relaxes the smooth muscles and expands the penile 
veins, increasing the blood flow pressure in the cav-
ernosum and results in erection.10,13,15 Additionally, 
NO activates the soluble guanylate cyclase, which 
catalyzes the conversion of guanosine triphosphate 
(GTP) to cGMP and leads to the activation of the 
PKG in the cavernosum smooth muscle cells. The 
PKG then phorphorylates ionic channels, decreases 
intracellular calcium concentration and results in 
a relaxation of the cavernosum smooth muscle.12
PDEs function as a cGMP-specific phosphodieste-
rase, which catalyzes the hydrolysis of cGMP to GMP.14 
The major isoform of PDE in humans is PDE-5 which 
is mainly expressed in the corpus cavernosum.16,17 
Previous studies have demonstrated that Viagra 
(Sildenafil) is a selective PDE-5 inhibitor, which will 
significantly increase the intra-cellular cGMP con-
centration in the corpora cavernosum, and is an 
excellent treatment for erectile dysfunction.18,19 
This study also showed that treatment with bur-
dock extract can inhibit the PDE-5 expression in 
cavernosum smooth muscle cells.
PKG is mainly distributed in smooth muscle cells, 
platelets and in the cerebellum.20 The main function 
of PKG is to activate the Ca2+-pumping ATPase, 
which will reduce intracellular calcium concentra-
tion. In addition, inactivation of sacroplasmic reti-
culum inositol 1,4,5-triphosphate receptors by PKG 
prevents Ca2+ release from the intracellular store.21,22 
Calcium ions activate myosin light chain kinase 
and contract the smooth muscle cells.23 Therefore, 
an increase in PKG activities will decrease intracellu-
lar calcium concentration and relax the smooth 
muscles. Our data showed that PKG expression in 
cavernosum smooth muscle cells increased after 
treatment with burdock extract.
sGC exists as an obligatory hemecontaining 
heterodimeric protein composed of α1- and β1-
subunits.24 When NO is increased, activation of sGC 
also increases, which in turn will convert GTP into 
cGMP.25 Therefore, activation of sGC can be used 
in treating erectile dysfunction.26
In conclusion, the results of this study demon-
strated that after treatment with burdock extract, 
expansion of the corpora cavernosum tissues can be 
achieved via activation of the NO-sGC-cGMP path-
ways. Burdock extract can increase protein expres-
sion of nNOS, PKG, sGCα1 and sGCβ1 in the cavernosum 
smooth muscles and inhibit PDE-5 expression. 
Meanwhile, burdock extract also induces increase 
in cGMP level in the cavernosum smooth muscles.
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